DP Biology (last assessment 2024)
Question 17N.2.HL.TZ0.02d.ii
| Date | November 2017 | Marks available | [Maximum mark: 1] | Reference code | 17N.2.HL.TZ0.02d.ii |
| Level | HL | Paper | 2 | Time zone | TZ0 |
| Command term | State | Question number | d.ii | Adapted from | N/A |
d.ii.
[Maximum mark: 1]
17N.2.HL.TZ0.02d.ii
(d.ii)
State one possible use of hybridoma cells.
[1]
Markscheme
produce monoclonal antibodies
OR
diagnosis of diseases/malaria/cancer/HIV
OR
treatment of rabies
OR
blood and tissue typing
OR
pregnancy testing
OR
targeting of cancer cells «with a chemotherapy drug»
OR
treatment of infection if too late for vaccination/successful immune response
Only accept the first use of hybridoma cells given in the answer
Not treatment of malaria
